Response to: Reply on "Renewed Helicobacter pylori management and therapy in 2015"
Main Authors: | Sharmila Fagoonee, Rinaldo Pellicano |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | The Saudi Journal of Gastroenterology |
Online Access: | http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2016;volume=22;issue=1;spage=81;epage=81;aulast=Fagoonee |
Similar Items
-
One or two weeks of treatment with Helicobacter Pylori ''standard'' triple therapy in the year 2015?
by: Rinaldo Pellicano, et al.
Published: (2015-01-01) -
Promises of Fibroblast Growth Factor Receptor–Directed Therapy in Tailored Cancer Treatment
by: Sharmila Fagoonee, et al.
Published: (2020-08-01) -
Does the Microbiota Play a Pivotal Role in the Pathogenesis of Irritable Bowel Syndrome?
by: Sharmila Fagoonee, et al.
Published: (2019-10-01) -
A Retrospective Experience of <i>Helicobacter pylori</i> Histology in a Large Sample of Subjects in Northern Italy
by: Davide Giuseppe Ribaldone, et al.
Published: (2021-07-01) -
Strategies for Helicobacter pylori eradication in the year 2020
by: Rinaldo Pellicano, et al.
Published: (2020-01-01)